In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates

被引：12
作者：
Cormican, MG
Jones, RN
机构：
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1996年 / 37卷 / 04期
关键词：
D O I：
10.1093/jac/37.4.847
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：847 / 849
页数：3
相关论文
共 7 条
[1]   In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates [J].
Cormican, MG ;
Jones, RN .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (04) :847-849
[2]   PRELIMINARY INTERPRETIVE CRITERIA FOR IN-VITRO SUSCEPTIBILITY TESTING OF CP-99219 BY DILUTION AND DISK DIFFUSION METHODS [J].
JONES, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 20 (03) :167-170
[3]   COMPARATIVE IN-VITRO ACTIVITY OF DU-6859A, A NEW FLUOROQUINOLONE AGENT, AGAINST GRAM-POSITIVE COCCI [J].
KORTEN, V ;
TOMAYKO, JF ;
MURRAY, BE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :611-615
[4]  
*NAT COMM CLIN LAB, 1993, PERF STAND ANT DISK
[5]  
*NAT COMM CLIN LAB, 1993, APPR STAND M7 A3 MET
[6]  
TENG R, 1993, 33 INT C ANT AG CHEM
[7]  
1993, MORBIDITY MORTALITY, V42, P597
1